Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salpingectomy vs Methotrexate in Ectopic Pregnancy
NCT02714998Completed
- Sponsor
- Ege University
- Start
- Jan 2013
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of methotrexate in Ectopic pregnancy (EP) (3 arms), sponsored by Ege University. Primary endpoint: Anti-Mullerian Hormone at 3 months. Started Jan 2013; status: completed.
02
Drugs
methotrexate
03
Conditions
Ectopic pregnancy (EP)
Beyond the preview
Go deeper on NCT02714998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02714998.